Non-muscle-invasive bladder cancer (NMIBC) has a high risk of recurrence and progression among patients without adequate Bacillus Calmette-Guérin.

The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say ...

Cannabis stocks fall as DOJ reschedules only FDA-approved and state-licensed medical marijuana to Schedule III.

Vermont’s medical and recreational cannabis markets are closely intertwined, complicating how the reclassification as a lower-risk drug could benefit Vermont businesses.

The order places FDA-approved products containing marijuana and state-regulated medical marijuana products at a lower drug ...

The federal government is reclassifying medical marijuana, categorizing it as a drug with potential medical benefits and less ...

Possessing marijuana is a federal crime punishable by fines and prison time. Selling or cultivating marijuana is a more ...

Acting Attorney General Todd Blanche signed an order Thursday reclassifying state-licensed marijuana as a less dangerous drug ...

Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which ...

ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio securities between January 19, 2026 and ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients ...

Antimicrobial (antibiotic)resistant infections are becoming more common and harder to treat. Antimicrobial resistance (AMR) arises when bacteria or other microbes change so that medicines no longer ...